Probiotic for hypersensitivity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Jan 2024: Trial started, NCT07490587
  2. 24 Mar 2026: Trial registered, NCT07490587

The trials

NCT07490587: To Investigate the Effects of Bifidobacterium Animalis Subsp. Lactis XLTG11 on Growth and Development, Incidence of Allergy and Immune Function in Infants

State
Under way
Phase
Phase 2
People
366 planned
Started
1 Jan 2024
Primary completion
30 Jun 2026
Arms
Probiotic
Results
None posted
  1. 1 Jan 2024: Trial started
  2. 24 Mar 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Diet or lifestyle.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.